• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Undertreatment of hypertension and the risk of stroke in the oldest old].

作者信息

Klungel O H, Stricker B H, Breteler M M, Seidell J C, de Boer A

机构信息

Utrecht Institute of Pharmaceutical Sciences (UIPS), Universiteit Utrecht.

出版信息

Tijdschr Gerontol Geriatr. 2000 Jun;31(3):119-22.

PMID:10900665
Abstract

The benefit of pharmacological treatment of hypertension in the prevention of cardiovascular diseases has been established mainly in subjects younger than 80 years of age. The consequences of undertreatment of hypertension with regard to the occurrence of stroke was studied in the Netherlands. About 33% of the hypertensives younger than 80 years and 55% of the hypertensives older than 80 years were not pharmacologically treated, although they were 'candidates' for pharmacological treatment of hypertension. About 19% (n = 1350) of all strokes that occurred in the Netherlands in 1994 among hypertensives younger than 80 years may be attributable to untreated hypertension. Among hypertensives older than 80 years this percentage was 32% (n = 1345). Although the benefit of pharmacological treatment of hypertension in persons older than 80 years has not been established experimentally, the results suggest that a considerable proportion of the strokes among this group of hypertensives may be prevented.

摘要

相似文献

1
[Undertreatment of hypertension and the risk of stroke in the oldest old].
Tijdschr Gerontol Geriatr. 2000 Jun;31(3):119-22.
2
Prevalence and determinants of undertreatment of hypertension in the Netherlands.荷兰高血压治疗不足的患病率及决定因素。
J Hum Hypertens. 2004 May;18(5):317-24. doi: 10.1038/sj.jhh.1001672.
3
Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.美国高血压成人患者在高血压治疗、药物使用模式及血压控制方面的性别差异:来自1999 - 2004年国家健康与营养检查调查的数据
Am J Hypertens. 2008 Jul;21(7):789-98. doi: 10.1038/ajh.2008.185. Epub 2008 May 1.
4
Excess stroke among hypertensive men and women attributable to undertreatment of hypertension.高血压治疗不足导致的高血压男性和女性中风过多。
Stroke. 1999 Jul;30(7):1312-8. doi: 10.1161/01.str.30.7.1312.
5
Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.葡萄牙初级保健中高血压的患病率及管理。来自VALSIM研究的见解。
Rev Port Cardiol. 2009 May;28(5):499-523.
6
Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.已确诊高血压患者的血压控制与药物治疗:一项意大利全科医疗调查
J Hum Hypertens. 2009 Nov;23(11):758-63. doi: 10.1038/jhh.2009.14. Epub 2009 Feb 26.
7
Treatment priorities and current prescribing patterns in hypertension: results of GRASP, an international physician survey.高血压的治疗优先级与当前处方模式:国际医师调查GRASP的结果
Curr Med Res Opin. 2004 Jul;20(7):1151-60. doi: 10.1185/030079904125004231.
8
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.老年单纯收缩期高血压患者的心血管事件。STOP-Hypertension-2研究中治疗策略的亚组分析。
Blood Press. 2004;13(3):137-41. doi: 10.1080/08037050410014944.
9
Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.氯沙坦在欧盟使用对中风的人群影响:来自氯沙坦干预降低高血压终点事件(LIFE)研究的预测
J Hum Hypertens. 2004 Jun;18(6):367-73. doi: 10.1038/sj.jhh.1001710.
10
Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly.老年人缺血性卒中后的血管事件、死亡率及预防性治疗
Neurology. 2005 Sep 27;65(6):835-42. doi: 10.1212/01.wnl.0000176058.09848.bb.